120 related articles for article (PubMed ID: 34826790)
1. Public health risks associated with methadone in Iran: A systematic review and meta-analysis.
Rostam-Abadi Y; Gholami J; Noroozi A; Ansari M; Baheshmat S; Hamzehzadeh M; Ghadirzadeh MR; Vahdani B; Ekhtiari H; Mojtabai R; Rahimi-Movaghar A
Int J Drug Policy; 2022 Feb; 100():103529. PubMed ID: 34826790
[TBL] [Abstract][Full Text] [Related]
2. Tramadol use and public health consequences in Iran: a systematic review and meta-analysis.
Rostam-Abadi Y; Gholami J; Amin-Esmaeili M; Safarcherati A; Mojtabai R; Ghadirzadeh MR; Rahimi H; Rahimi-Movaghar A
Addiction; 2020 Dec; 115(12):2213-2242. PubMed ID: 32196801
[TBL] [Abstract][Full Text] [Related]
3. Buprenorphine abuse and health risks in Iran: A systematic review.
Ansari M; Rostam-Abadi Y; Baheshmat S; Hamzehzadeh M; Gholami J; Mojtabai R; Rahimi-Movaghar A
Drug Alcohol Depend; 2021 Sep; 226():108871. PubMed ID: 34214882
[TBL] [Abstract][Full Text] [Related]
4. Supervised dosing with a long-acting opioid medication in the management of opioid dependence.
Saulle R; Vecchi S; Gowing L
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011983. PubMed ID: 28447766
[TBL] [Abstract][Full Text] [Related]
5. Do interruptions to the continuity of methadone maintenance treatment in specialist addiction settings increase the risk of drug-related poisoning deaths? A retrospective cohort study.
Durand L; O'Driscoll D; Boland F; Keenan E; Ryan BK; Barry J; Bennett K; Fahey T; Cousins G
Addiction; 2020 Oct; 115(10):1867-1877. PubMed ID: 32034837
[TBL] [Abstract][Full Text] [Related]
6. Perceived barriers to methadone maintenance treatment among Iranian opioid users.
Khazaee-Pool M; Moeeni M; Ponnet K; Fallahi A; Jahangiri L; Pashaei T
Int J Equity Health; 2018 Jun; 17(1):75. PubMed ID: 29890990
[TBL] [Abstract][Full Text] [Related]
7. Medication-assisted treatment with methadone: assessing the evidence.
Fullerton CA; Kim M; Thomas CP; Lyman DR; Montejano LB; Dougherty RH; Daniels AS; Ghose SS; Delphin-Rittmon ME
Psychiatr Serv; 2014 Feb; 65(2):146-57. PubMed ID: 24248468
[TBL] [Abstract][Full Text] [Related]
8. Risk of motor vehicle collisions after methadone use.
Yang YH; Ho PS; Wu TN; Wang PW; Lin CR; Tsai JH; Guo YL; Chuang HY
Elife; 2021 Aug; 10():. PubMed ID: 34351275
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of an implementation of methadone maintenance treatment in China.
Marienfeld C; Liu P; Wang X; Schottenfeld R; Zhou W; Chawarski MC
Drug Alcohol Depend; 2015 Dec; 157():60-7. PubMed ID: 26601934
[TBL] [Abstract][Full Text] [Related]
10. Association Between Socio-Demographic and Health Functioning Variables Among Patients with Opioid Use Disorder Introduced by Prescription: A Prospective Cohort Study.
Sanger N; Bhatt M; Shams I; Shahid H; Luo C; Tam SL; Samaan MC; de Souza R; Thabane L; Samaan Z
Pain Physician; 2018 Nov; 21(6):E623-E632. PubMed ID: 30508993
[TBL] [Abstract][Full Text] [Related]
11. Scaling up methadone maintenance treatment for opioid-dependent prisoners in Iran.
Farnia M; Ebrahimi B; Shams A; Zamani S
Int J Drug Policy; 2010 Sep; 21(5):422-4. PubMed ID: 20413287
[TBL] [Abstract][Full Text] [Related]
12. Are infants exposed to methadone in utero at an increased risk for mortality?
Kelly LE; Rieder MJ; Bridgman-Acker K; Lauwers A; Madadi P; Koren G
J Popul Ther Clin Pharmacol; 2012; 19(2):e160-5. PubMed ID: 22580362
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with methadone maintenance therapy discontinuation among people who inject drugs.
Lo A; Kerr T; Hayashi K; Milloy MJ; Nosova E; Liu Y; Fairbairn N
J Subst Abuse Treat; 2018 Nov; 94():41-46. PubMed ID: 30243416
[TBL] [Abstract][Full Text] [Related]
14. Prenatal methadone exposure disrupts behavioral development and alters motor neuron intrinsic properties and local circuitry.
Grecco GG; Mork BE; Huang JY; Metzger CE; Haggerty DL; Reeves KC; Gao Y; Hoffman H; Katner SN; Masters AR; Morris CW; Newell EA; Engleman EA; Baucum AJ; Kim J; Yamamoto BK; Allen MR; Wu YC; Lu HC; Sheets PL; Atwood BK
Elife; 2021 Mar; 10():. PubMed ID: 33724184
[TBL] [Abstract][Full Text] [Related]
15. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.
Sordo L; Barrio G; Bravo MJ; Indave BI; Degenhardt L; Wiessing L; Ferri M; Pastor-Barriuso R
BMJ; 2017 Apr; 357():j1550. PubMed ID: 28446428
[No Abstract] [Full Text] [Related]
16. Predictors of treatment retention in a major methadone maintenance treatment program in iran: a survival analysis.
Pashaei T; Moeeni M; Roshanaei Moghdam B; Heydari H; Turner NE; Razaghi EM
J Res Health Sci; 2014; 14(4):291-5. PubMed ID: 25503286
[TBL] [Abstract][Full Text] [Related]
17. Non-prescribed use of methadone and buprenorphine prior to opioid substitution treatment: lifetime prevalence, motives, and drug sources among people with opioid dependence in five Swedish cities.
Johnson B; Richert T
Harm Reduct J; 2019 May; 16(1):31. PubMed ID: 31046774
[TBL] [Abstract][Full Text] [Related]
18. Insomnia and excessive daytime sleepiness in women and men receiving methadone and buprenorphine maintenance treatment.
Hallinan R; Elsayed M; Espinoza D; Veillard AS; Morley KC; Lintzeris N; Haber P
Subst Use Misuse; 2019; 54(10):1589-1598. PubMed ID: 31131668
[No Abstract] [Full Text] [Related]
19. Loneliness and Illicit Opioid Use Among Methadone Maintenance Treatment Patients.
Polenick CA; Cotton BP; Bryson WC; Birditt KS
Subst Use Misuse; 2019; 54(13):2089-2098. PubMed ID: 31232142
[No Abstract] [Full Text] [Related]
20. Characteristics of methadone maintenance treatment patients prescribed opioid analgesics.
Glenn MC; Sohler NL; Starrels JL; Maradiaga J; Jost JJ; Arnsten JH; Cunningham CO
Subst Abus; 2016; 37(3):387-391. PubMed ID: 26731299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
